Enzon Pharmaceuticals, Inc.

DB:EZ1 Stock Report

Market Cap: €6.2m

Enzon Pharmaceuticals Ownership

Who are the major shareholders and have insiders been buying or selling?


Recent Insider Transactions

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

What is the ownership structure of EZ1?
Owner TypeNumber of SharesOwnership Percentage
Public Companies633,2640.853%
Private Companies2,043,0242.75%
Individual Insiders5,367,6667.23%
General Public30,114,01340.6%
Institutions36,056,63648.6%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.


Top Shareholders

Top 6 shareholders own 59.42% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
48.6%
Icahn Capital LP
36,056,636€3.0m0%0.03%
6.83%
Jonathan Couchman
5,067,666€424.9k0%no data
2.75%
Xstelos Holdings, Inc.
2,043,024€171.3k0%no data
0.85%
Myrexis, Inc.
633,264€53.1k0%no data
0.27%
Randolph Read
200,000€16.8k0%no data
0.13%
Jordan Bleznick
100,000€8.4k0%no data